Search - tctmd.com

Displaying 621 - 640 of 697

Sort: Relevancy | Date

News Daily News

Longer DAPT Duration Reduces Adverse Events After PCI for In-Stent Restenosis

Caitlin E. Cox

October 23, 2013

News Daily News

无并发症DES患者长期使用阿司匹林与双联疗法效果相同

Jason Kahn

October 11, 2013

News Daily News

Long-term Aspirin as Effective as Dual Therapy in Uncomplicated DES Patients

Jason Kahn

October 11, 2013

News Daily News

ESC Consensus Statement Outlines Proper Role of Platelet Function Testing After PCI

September 30, 2013

News Daily News

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

September 20, 2013

Presentation

Outcomes with Various DES or BMS in Patients with STEMI: Mixed Treatment Comparison Analysis

Presenter: Sripal Bangalore

August 13, 2013

News Daily News

PCI-Related Stroke Rate Exceedingly Low but Linked to Poor Prognosis

Yael L. Maxwell

August 09, 2013

News Daily News

El Índice de ACV secundarios a una PCI es Muy Bajo, si bien el Pronóstico es Malo

Yael L. Maxwell

August 09, 2013

News Daily News

第一代药物洗脱支架与金属裸支架在ST段抬高心肌梗死的治疗中相比，患者的长期心源性死亡率更高

July 24, 2013

News Daily News

More Long-term Cardiac Mortality with First-Generation DES vs. BMS for STEMI

July 24, 2013

News Daily News

Mayor mortalidad cardíaca a largo plazo con la primera generación de SLF vs. SMD para STEMI

July 24, 2013

News Daily News

HORIZONS-AMI: La Bivalirudina y Taxus Mejoran los Resultados en Pacientes sometidos a una PCI en la Arteria Descendente Anterior Izda

Leah Lawrence

July 11, 2013

News Daily News

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Leah Lawrence

July 11, 2013

Presentation

Impact of Bivalirudin and Paclitaxel-Eluting Stents on Outcomes in Patients Undergoing Primary PCI of the LAD

Presenter: Jochen W?hrle

July 09, 2013

Presentation

Long-term Outcome After Drug-Eluting vs. Bare-Metal Stent Implantation in Patients with STEMI

Presenter: L. Holmvang

June 24, 2013

Presentation

CRISP: Remote Ischemic Preconditioning Improves Outcome at 6 Years After Elective PCI

Presenter: 212604|Will Davies

June 11, 2013

Presentation

Clinical Outcomes with Drug-Eluting and Bare-Metal Stents in Patients with STEMI

Presenter: T. Palmerini

June 04, 2013

News Conference News EuroPCR 2013

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Caitlin E. Cox

May 29, 2013

News Conference News EuroPCR 2013

COMFORTABLE-AMI: Biodegradable-Polymer DES Offers Lasting Benefit to STEMI Patients

Caitlin E. Cox

May 23, 2013

News Daily News

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

Jason Kahn

January 22, 2013

Advertisement

Longer DAPT Duration Reduces Adverse Events After PCI for In-Stent Restenosis

无并发症DES患者长期使用阿司匹林与双联疗法效果相同

Long-term Aspirin as Effective as Dual Therapy in Uncomplicated DES Patients

ESC Consensus Statement Outlines Proper Role of Platelet Function Testing After PCI

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

Outcomes with Various DES or BMS in Patients with STEMI: Mixed Treatment Comparison Analysis

PCI-Related Stroke Rate Exceedingly Low but Linked to Poor Prognosis

El Índice de ACV secundarios a una PCI es Muy Bajo, si bien el Pronóstico es Malo

第一代药物洗脱支架与金属裸支架在ST段抬高心肌梗死的治疗中相比，患者的长期心源性死亡率更高

More Long-term Cardiac Mortality with First-Generation DES vs. BMS for STEMI

Mayor mortalidad cardíaca a largo plazo con la primera generación de SLF vs. SMD para STEMI

HORIZONS-AMI: La Bivalirudina y Taxus Mejoran los Resultados en Pacientes sometidos a una PCI en la Arteria Descendente Anterior Izda

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Impact of Bivalirudin and Paclitaxel-Eluting Stents on Outcomes in Patients Undergoing Primary PCI of the LAD

Long-term Outcome After Drug-Eluting vs. Bare-Metal Stent Implantation in Patients with STEMI

CRISP: Remote Ischemic Preconditioning Improves Outcome at 6 Years After Elective PCI

Clinical Outcomes with Drug-Eluting and Bare-Metal Stents in Patients with STEMI

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

COMFORTABLE-AMI: Biodegradable-Polymer DES Offers Lasting Benefit to STEMI Patients

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content